874013-97-5

Basic information

• Product Name: 7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine
• Synonyms: 7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine;7-Chloro-2-Methyl-6-azaindole;7-Chloro-2-methyl-1H-pyrrolo[2,3-c]pyrdine
• CAS NO: 874013-97-5
• Molecular Formula: C8H7ClN2
• Molecular Weight: 166.60758
• Mol File: 874013-97-5.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine(874013-97-5)
• EPA Substance Registry System: 7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine(874013-97-5)

Safety Data

• Hazardous Substances Data: 874013-97-5(Hazardous Substances Data)

Usage

General Description

7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine is a chemical compound with the molecular formula C8H6ClN3. It is a heterocyclic aromatic compound that contains both a pyrrole ring and a pyridine ring. 7-Chloro-2-Methyl-1H-pyrrolo[2,3-c]pyridine is commonly used in the pharmaceutical industry as a building block for the synthesis of various pharmaceutical drugs and biologically active molecules. It has been studied for its potential therapeutic applications, particularly in the treatment of various diseases and disorders. Additionally, it is also used as a research tool in medicinal chemistry and drug discovery. However, it is important to handle and use this compound with caution, as it may pose health and safety hazards if not properly managed.

Upstream product

• 5470-18-8 2-Chloro-3-nitropyridine 
• 13154-14-8 1-propenylmagnesium bromide 
• 1415124-77-4 7-chloro-2-methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-c]pyridine 
• 920-39-8 isopropylmagnesium bromide 

Relevant articles and documents

Molecular modeling, design, synthesis, and biological activity of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives as potassium-competitive acid blockers

A series of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives were designed and synthesized based on our docking model as potassium-competitive acid blockers (P-CABs). Molecular modeling of these derivatives led us to introduce a substituent at the 1-position

HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS

The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A' B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.